558 related articles for article (PubMed ID: 17973265)
21. Value of immunohistochemical detection of DNA mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms.
Shia J; Klimstra DS; Nafa K; Offit K; Guillem JG; Markowitz AJ; Gerald WL; Ellis NA
Am J Surg Pathol; 2005 Jan; 29(1):96-104. PubMed ID: 15613860
[TBL] [Abstract][Full Text] [Related]
22. Clinical findings with implications for genetic testing in families with clustering of colorectal cancer.
Wijnen JT; Vasen HF; Khan PM; Zwinderman AH; van der Klift H; Mulder A; Tops C; Møller P; Fodde R
N Engl J Med; 1998 Aug; 339(8):511-8. PubMed ID: 9709044
[TBL] [Abstract][Full Text] [Related]
23. Use of molecular tumor characteristics to prioritize mismatch repair gene testing in early-onset colorectal cancer.
Southey MC; Jenkins MA; Mead L; Whitty J; Trivett M; Tesoriero AA; Smith LD; Jennings K; Grubb G; Royce SG; Walsh MD; Barker MA; Young JP; Jass JR; St John DJ; Macrae FA; Giles GG; Hopper JL
J Clin Oncol; 2005 Sep; 23(27):6524-32. PubMed ID: 16116158
[TBL] [Abstract][Full Text] [Related]
24. Association of hereditary nonpolyposis colorectal cancer-related tumors displaying low microsatellite instability with MSH6 germline mutations.
Wu Y; Berends MJ; Mensink RG; Kempinga C; Sijmons RH; van Der Zee AG; Hollema H; Kleibeuker JH; Buys CH; Hofstra RM
Am J Hum Genet; 1999 Nov; 65(5):1291-8. PubMed ID: 10521294
[TBL] [Abstract][Full Text] [Related]
25. Detection of mismatch repair gene germline mutation carrier among Chinese population with colorectal cancer.
Jin HY; Liu X; Li VK; Ding Y; Yang B; Geng J; Lai R; Ding S; Ni M; Zhao R
BMC Cancer; 2008 Feb; 8():44. PubMed ID: 18257912
[TBL] [Abstract][Full Text] [Related]
26. Differential features of colorectal cancers fulfilling Amsterdam criteria without involvement of the mutator pathway.
Llor X; Pons E; Xicola RM; Castells A; Alenda C; Piñol V; Andreu M; Castellví-Bel S; Payá A; Jover R; Bessa X; Girós A; Roca A; Gassull MA;
Clin Cancer Res; 2005 Oct; 11(20):7304-10. PubMed ID: 16243801
[TBL] [Abstract][Full Text] [Related]
27. Prospective determination of prevalence of lynch syndrome in young women with endometrial cancer.
Lu KH; Schorge JO; Rodabaugh KJ; Daniels MS; Sun CC; Soliman PT; White KG; Luthra R; Gershenson DM; Broaddus RR
J Clin Oncol; 2007 Nov; 25(33):5158-64. PubMed ID: 17925543
[TBL] [Abstract][Full Text] [Related]
28. Mutation analysis of the MLH1, MSH2 and MSH6 genes in patients with double primary cancers of the colorectum and the endometrium: a population-based study in northern Sweden.
Cederquist K; Emanuelsson M; Göransson I; Holinski-Feder E; Müller-Koch Y; Golovleva I; Grönberg H
Int J Cancer; 2004 Apr; 109(3):370-6. PubMed ID: 14961575
[TBL] [Abstract][Full Text] [Related]
29. HNPCC: six new pathogenic mutations.
Kunstmann E; Vieland J; Brasch FE; Hahn SA; Epplen JT; Schulmann K; Schmiegel W
BMC Med Genet; 2004 Jun; 5():16. PubMed ID: 15217520
[TBL] [Abstract][Full Text] [Related]
30. Atypical HNPCC owing to MSH6 germline mutations: analysis of a large Dutch pedigree.
Wagner A; Hendriks Y; Meijers-Heijboer EJ; de Leeuw WJ; Morreau H; Hofstra R; Tops C; Bik E; Bröcker-Vriends AH; van Der Meer C; Lindhout D; Vasen HF; Breuning MH; Cornelisse CJ; van Krimpen C; Niermeijer MF; Zwinderman AH; Wijnen J; Fodde R
J Med Genet; 2001 May; 38(5):318-22. PubMed ID: 11333868
[TBL] [Abstract][Full Text] [Related]
31. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients.
Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A
Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385
[TBL] [Abstract][Full Text] [Related]
32. MSH6 germline mutations are rare in colorectal cancer families.
Peterlongo P; Nafa K; Lerman GS; Glogowski E; Shia J; Ye TZ; Markowitz AJ; Guillem JG; Kolachana P; Boyd JA; Offit K; Ellis NA
Int J Cancer; 2003 Nov; 107(4):571-9. PubMed ID: 14520694
[TBL] [Abstract][Full Text] [Related]
33. Identification of germline MSH2 gene mutations in endometrial cancer not fulfilling the new clinical criteria for hereditary nonpolyposis colorectal cancer.
Banno K; Susumu N; Hirao T; Yanokura M; Hirasawa A; Aoki D; Udagawa Y; Sugano K; Nozawa S
Cancer Genet Cytogenet; 2003 Oct; 146(1):58-65. PubMed ID: 14499697
[TBL] [Abstract][Full Text] [Related]
34. Spectrum and frequencies of mutations in MSH2 and MLH1 identified in 1,721 German families suspected of hereditary nonpolyposis colorectal cancer.
Mangold E; Pagenstecher C; Friedl W; Mathiak M; Buettner R; Engel C; Loeffler M; Holinski-Feder E; Müller-Koch Y; Keller G; Schackert HK; Krüger S; Goecke T; Moeslein G; Kloor M; Gebert J; Kunstmann E; Schulmann K; Rüschoff J; Propping P
Int J Cancer; 2005 Sep; 116(5):692-702. PubMed ID: 15849733
[TBL] [Abstract][Full Text] [Related]
35. Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance.
Hendriks YM; Wagner A; Morreau H; Menko F; Stormorken A; Quehenberger F; Sandkuijl L; Møller P; Genuardi M; Van Houwelingen H; Tops C; Van Puijenbroek M; Verkuijlen P; Kenter G; Van Mil A; Meijers-Heijboer H; Tan GB; Breuning MH; Fodde R; Wijnen JT; Bröcker-Vriends AH; Vasen H
Gastroenterology; 2004 Jul; 127(1):17-25. PubMed ID: 15236168
[TBL] [Abstract][Full Text] [Related]
36. Genetic testing for hereditary nonpolyposis colorectal cancer (HNPCC).
Hegde MR; Roa BB
Curr Protoc Hum Genet; 2009 Apr; Chapter 10():Unit 10.12. PubMed ID: 19360696
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of germline mutations of MLH1 and MSH2 in hereditary nonpolyposis colorectal cancer families from Spain.
Caldes T; Godino J; de la Hoya M; Garcia Carbonero I; Perez Segura P; Eng C; Benito M; Diaz-Rubio E
Int J Cancer; 2002 Apr; 98(5):774-9. PubMed ID: 11920650
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of familial endometrial carcinoma: a manifestation of hereditary nonpolyposis colorectal cancer or a separate syndrome?
Ollikainen M; Abdel-Rahman WM; Moisio AL; Lindroos A; Kariola R; Järvelä I; Pöyhönen M; Butzow R; Peltomäki P
J Clin Oncol; 2005 Jul; 23(21):4609-16. PubMed ID: 15837969
[TBL] [Abstract][Full Text] [Related]
39. Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Bonadona V; Bonaïti B; Olschwang S; Grandjouan S; Huiart L; Longy M; Guimbaud R; Buecher B; Bignon YJ; Caron O; Colas C; Noguès C; Lejeune-Dumoulin S; Olivier-Faivre L; Polycarpe-Osaer F; Nguyen TD; Desseigne F; Saurin JC; Berthet P; Leroux D; Duffour J; Manouvrier S; Frébourg T; Sobol H; Lasset C; Bonaïti-Pellié C;
JAMA; 2011 Jun; 305(22):2304-10. PubMed ID: 21642682
[TBL] [Abstract][Full Text] [Related]
40. Mismatch repair defective breast cancer in the hereditary nonpolyposis colorectal cancer syndrome.
Jensen UB; Sunde L; Timshel S; Halvarsson B; Nissen A; Bernstein I; Nilbert M
Breast Cancer Res Treat; 2010 Apr; 120(3):777-82. PubMed ID: 19575290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]